New Zinc Phosphates
2.0 mmol), sodium hydroxide (80.0, 2.0 mmol), D-histidine
hydrochloride (383.2 mg, 2.0 mmol), and water (6 mL) for 10 days
at 125 °C yields a colorless needle crystalline product. Yield: 82%
on the basis of zinc source. FT-IR (cm-1): 3133(w), 3002(w),
2926(w), 1618(m), 1586(m), 1492(m), 1414(m), 1344(m), 1310(m),
1310(m), 1270(m), 1101 (s), 1082(s), 992(s), 971(s), 911(s), 847(s),
770(m), 752(m), 683(s), 664(s). Anal. Calcd for C6H10N3O6PZn:
C, 22.77; H, 3.18; N, 13.28. Found: C, 22.52; H, 3.43; N, 13.09.
[Zn(HPO4)(C4H6N2)]‚H2O (2). Hydrothermal treatment of zinc
nitrate hexahydrate (297.5 mg, 1.0 mmol), phosphoric acid (85 wt
%, 230.6 mg, 2.0 mmol), 1-methylimidazole (492.7 mg, 6.0 mmol),
and water (6 mL) for 10 days at 125 °C yields a colorless
microcrystalline product. This sample was allowed to stand in the
mother liquid for several weeks, and then needle crystals were
collected. Yield: 31% on the basis of zinc source. FT-IR (cm-1):
3377(w), 3125(m), 2929(w), 1544(m), 1530(m), 1290(w), 1254-
(w), 1207(w), 1141(m), 1021(s), 955(m), 911(m), 861(m), 848-
(m), 780(m), 770(m), 675(m). Anal. Calcd for C4H9N2O5PZn: C,
18.37; H, 3.47; N, 10.71. Found: C, 18.16; H, 3. 49; N, 10.58.
The weight loss (26 to ∼159 °C) corresponds to the loss of lattice
water molecules (obsd 7.0%, 1H2O calcd 6.9%). This compound
is stable up to 197 °C as shown in the TGA curve.
[Zn2(HPO4)2(C14H14N4)]‚2H2O (3). Hydrothermal treatment of
zinc acetate dihydrate (65.8 mg, 0.3 mmol), potassium dihydro-
genphosphate (81.6 mg, 0.6 mmol), 1,4-bis(imidazol-1-ylmethyl)-
benzene (71.4, 0.3 mmol), and water (6 mL) for 9 days at 130 °C
yields a needle crystalline product. Yield: 89% on the basis of
zinc source. FT-IR (cm-1): 3357(w), 3146(w), 3130(w), 1526(m),
1440(m), 1238(m), 1132(m), 1088(s), 1021(s), 952(m), 911(s),
844(m), 805(m), 735(s). Anal. Calcd for C14H20N4O10P2Zn2: C,
28.16; H, 3.38; N, 9.38. Found: C, 27.73; H, 3.56; N, 9.22. The
weight loss (23 to ∼163 °C) corresponds to the loss of lattice water
molecules (obsd 5.9%, 2H2O calcd 6.0%). This compound is stable
up to 312 °C as shown in the TGA curve.
which the four rings may be ligated and linked. Yet, although
many of the structures can be readily rationalized as deriving
from the four rings, there are no rational syntheses available
for a given structural motif. Indeed, the same templating or
ligating group can lead to several different structures
depending on temperature, concentration, and pH.6 However,
it is recognized that the construction of extended structures
via molecular building blocks offers great potential for the
design of materials.7 For example, very recently the Natarajan
group combined the principles of supramolecular organic
chemistry with inorganic building units to form new zinc
phosphate solids.5c
The goal of our research is to synthesize zinc phosphates
decorated by ancillary ligands and at the same time try to
understand the role of the ancillary ligands in the formation
of these solids. According to this approach, D-histidine,
1-methylimidazole, 1,4-bis(imidazol-1-ylmethyl)benzene, and
1,2-bis(imidazol-1-ylmethyl)benzene were used as ancillary
ligands. Here, we report the synthesis, structure, and
characterization of four new zinc phosphates: [Zn(HPO4)-
(C6H9N3O2)] (1), [Zn(HPO4)(C4H6N2)]‚H2O (2), [Zn2(HPO4)2-
(C14H14N4)]‚2H2O (3), and [Zn(HPO4)(C14H14N4)]‚H2O (4).
Compounds 1 and 2 have the same framework backbone,
an edge-shared ladder structure. In 3 edge-shared ladder
structures, as observed in 1 and 2, are linked by 1,4-bis-
(imidazol-1-ylmethyl)benzene to form a novel 2D structure.
In 4 the linear ligand 1,2-bis(imidazol-1-ylmethyl)benzene
connects the four-ring building blocks to generate a new
structural motif with the four rings linked face-to-face.
Experimental Section
[Zn(HPO4)(C14H14N4)]‚H2O (4). Hydrothermal treatment of zinc
acetate dihydrate (65.8 mg, 0.3 mmol), potassium dihydrogenphos-
phate (81.6 mg, 0.6 mmol), 1,2-bis(imidazol-1-ylmethyl)benzene
(71.4, 0.3 mmol), and water (6 mL) for 5 days at 125 °C yields a
block crystalline product. Yield: 81% on the basis of zinc source.
FT-IR (cm-1): 3422(w), 3127(m), 1529(m), 1520(m), 1455(m),
1445(m), 1364(m), 1280(w), 1250(w), 1106(s), 1071(s), 1028(m),
979(m), 952(s), 890(m), 844(m), 764(s), 748(s). Anal. Calcd for
C14H17N4O5PZn: C, 40.26; H, 4.10; N, 13.41. Found: C, 39.54;
H, 4.37; N, 13.17. The weight loss (23 to ∼255 °C) corresponds
to the loss of lattice water molecules (obsd 4.4%, 1H2O calcd 4.3%).
This compound is stable up to 311 °C as shown in the TGA curve.
Crystallographic Analyses. Low-temperature (100 K) single-
crystal X-ray diffraction measurements for complexes 1-4 were
collected on a Oxford Diffraction Xcalibur2 diffractometer equipped
with the Enhance X-ray source and a Sapphire 2 CCD detector.
The data collection routine, unit cell refinement, and data processing
were carried out with the program CrysAlis.10 The structure was
solved by direct methods using SHELXS-97 and refined by full-
matrix least-squares.11 The final refinements involved an anisotropic
model for all non-hydrogen atoms. Hydrogen atoms were either
located from the residual e- density map and refined independently
or located by a riding model. The crystal parameters, data collection,
and refinement results for compounds 1-4 are summarized in Table
Materials and Measurements. All commercially available
chemicals are of reagent grade and used as received without further
purification. The ligands 1,4-bis(imidazol-1-ylmethyl)benzene8a,b
and 1,2-bis(imidazol-1-ylmethyl)benzene8c were synthesized by the
reaction of imidazole with R,R′-dibromo-p-xylene and R,R′-
dibromo-o-xylene, respectively, with the same procedures reported
for preparation of 1,3,5-tris(imidazol-1-ylmethyl)-2,4,6-trimethyl-
benzene.9 Elemental analyses of C, H, and N were performed by
Galbraith Laboratories, Inc. Thermogravimetric measurements were
performed on a TA Instruments Q500 thermal analyzer in N2 with
the heating rate of 10 °C min-1
.
[Zn(HPO4)(C6H9N3O2)] (1). Hydrothermal treatment of zinc
oxide (81.4 mg, 1.0 mmol), phosphoric acid (85 wt %, 230.6 mg,
(5) (a) Liu, W.; Liu, Y.; Shi, Z.; Pang, W. J. Mater. Chem. 2000, 10,
1451. (b) Ayi, A. A.; Choudhury, A.; Natarajan, S.; Rao, C. N. R. J.
Mater. Chem. 2001, 11, 1181. (c) Natarajan, S.; Wullen, L. V.; Klein,
W.; Jansen, M. Inorg. Chem. 2003, 42, 6265. (d) Choudhury, A.;
Neeraj, S.; Natarajan, S.; Rao, C. N. R. J. Mater. Chem. 2001, 11,
1537.
(6) (a) Neeraj, S.; Natarajan, S. Chem. Mater. 2000, 12, 2753. (b)
Choudhury, A.; Natarajan, S.; Rao, C. N. R. Inorg. Chem. 2000, 39,
4295.
(7) (a) Fe´rey, G. J. Solid State Chem. 2000, 152, 37. (b) Murugavel, R.;
Walawalkar, D. M.; Roesky, H. W.; Rao, C. N. R. Acc. Chem. Res.
2004, in press.
(8) (a) Dahl, P. K.; Arnold, F. H. Macromolecules 1992, 25, 7051. (b)
Abrahams, B. F.; Hoskins, B. F.; Robson, R.; Slizys, D. A. Crys-
tEngComm 2002, 4, 478. (c) Tan, H. Y.; Zhang, H. X.; Ou, H. D.;
Kang, B. S. Inorg. Chim. Acta 2004, 357, 869.
(10) CrysAlis v1.171; Oxford Diffraction: Wroclaw, Poland, 2004.
(11) (a) Sheldrick, G. M. SHELXS97, Program for Crystal Structure
Determination; University of Go¨ttingen: Go¨ttingen, Germany, 1997.
(b) Sheldrick, G. M. SHELXL97, Program for Crystal Structural
Refinement; University of Go¨ttingen: Go¨ttingen, Germany, 1997.
(9) (a) Sun, W. Y.; Fan, J.; Okamura, T.-a.; Xie, J.; Yu, K. B.; Ueyama,
N. Chem. Eur. J. 2001, 7, 2557. (b) Liu, H. K.; Sun, W. Y.; Zhu, H.
L.; Yu, K. B.; Tang, W. X. Inorg. Chim. Acta 1999, 295, 129.
Inorganic Chemistry, Vol. 44, No. 3, 2005 553